1. Home
  2. PRPL vs IRIX Comparison

PRPL vs IRIX Comparison

Compare PRPL & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Purple Innovation Inc.

PRPL

Purple Innovation Inc.

HOLD

Current Price

$2.53

Market Cap

13.9M

ML Signal

HOLD

Logo IRIDEX Corporation

IRIX

IRIDEX Corporation

HOLD

Current Price

$0.63

Market Cap

15.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRPL
IRIX
Founded
2010
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.9M
15.0M
IPO Year
2015
1996

Fundamental Metrics

Financial Performance
Metric
PRPL
IRIX
Price
$2.53
$0.63
Analyst Decision
Hold
Analyst Count
2
0
Target Price
★ $0.65
N/A
AVG Volume (30 Days)
55.1K
★ 58.0K
Earning Date
04-28-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 152.75
51.85
EPS
N/A
★ N/A
Revenue
★ $468,725,000.00
$41,593,000.00
Revenue This Year
$8.50
$3.07
Revenue Next Year
$6.68
$6.66
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.28
$0.61
52 Week High
$10.00
$1.65

Technical Indicators

Market Signals
Indicator
PRPL
IRIX
Relative Strength Index (RSI) 32.97 33.85
Support Level $0.49 $0.61
Resistance Level $10.00 $0.98
Average True Range (ATR) 0.29 0.03
MACD -0.02 0.01
Stochastic Oscillator 18.87 24.79

Price Performance

Historical Comparison
PRPL
IRIX

About PRPL Purple Innovation Inc.

Purple Innovation Inc designs and manufactures sleep products. Using its GelFlex Grid technology, the company designs, manufactures, and offers branded comfort sleep products, including mattresses, pillows, cushions, mattress protectors, bases, sheets, and others. It markets and sells these products through direct-to-consumer e-commerce channels, retail brick-and-mortar wholesale partners, Purple showrooms, and third-party online retailers.

About IRIX IRIDEX Corporation

IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

Share on Social Networks: